250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 10 Life Science VC Funds in Norway

A list of 10 VC funds that invest in Life science startups based in Norway. We rank investors based on the number of investments they made in Life science companies from Norway. We update this investor list every month.

Top 10 Life Science VC Funds in Norway

Investor Life Science Norway investments
Investinor 2
SINTEF Venture AS 1
Dynamk Capital 1
Hadean Ventures 1
Birk Venture 1
The Index Project 1
Canica 1
Project Sandwater 1
Nordic Impact 1
Bakken & Baeck 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Investinor VC Fund · Trondheim, Sor-Trondelag, Norway
Investinor invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion. The company has BNOK 4.2 ($500 m) under management and focus on companies within the internet, software, semiconductors, energy, cleantech, marine and life sciences sectors.
Show more
Investment focus
  • Software, Biotechnology, Manufacturing
  • Funding Round, Seed, Series A
  • Norway, United States, Switzerland
Portfolio highlights
  • Eyr — Eyr offers digital tools for medical consulting and doctor's prescription regarding various health issues.
  • Nomono — The Next Generation Audio company.
  • Calluna Pharma — Join Calluna Pharma on our mission to revolutionize the treatment of inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, help us reshape the treatment landscape for the better.
SINTEF Venture AS VC Fund · Trondheim, Sor-Trondelag, Norway
SINTEF TTO & Venture invest in spin-off companies from SINTEF, NTNU and other research based institutions in Norway. Our dealflow reflect results from state-of-art research and cover a variety of sectors. SINTEF Venture seek to co-invest with VC funds with sector expertise at an early stage.
Show more
Investment focus
  • Manufacturing, Software, Energy
  • Seed, Funding Round, Pre-Seed
  • Norway, United States, United Kingdom
Portfolio highlights
  • Nomono — The Next Generation Audio company.
  • Hystar — Hystar develops polymer electrolyte membrane electrolyzers designed for large-scale green hydrogen production. Founded in 2020, Hystar's technology uses a unique cell design and process architecture that provides the ability to reduce electricity consumption and increase hydrogen output, enabling professionals to tackle various criticalenergy challenges and having the potential to reduce greenhouse gas emissions.
  • KIT-AR — Reduce time and costs spent fixing errors on your manufacturing shopfloor with quality assurance and augmented reality- Click in to find how!
Dynamk Capital VC Fund · New York, New York, United States · 2 investments in the past 12 months
Dynamk Capital is a New York headquartered growth equity and venture capital firm investing in life science industrials: tools, technologies and services that are critical for the discovery, development and production of life-saving therapies. Venture capital for Life Science tools.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Series A, Seed, Series B
  • United States, Canada, Norway
Portfolio highlights
  • CellFE — We transform the way gene therapies are manufactured to enable affordable advanced treatments for all.
  • Lucid Scientific — Lucid Scientific is the maker of Resipher - the world's first handheld cell culture monitor to measure real-time oxygen consumption from inside an incubator.
  • Vernal Biosciences — Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Hadean Ventures VC Fund · Oslo, Oslo, Norway
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Funding Round, Series B
  • Sweden, Norway, Austria
Portfolio highlights
  • Ribbon Biolabs — Ribbon Biolabs revolutionary technology for the fast and efficient automated synthesis of DNA is here to enable the new wave of biotechnological innovation.
  • Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Birk Venture VC Fund · Oslo, Oslo, Norway
Birk Venture is a Scandinavian venture company exclusively focusing on the life science industry.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Series A, Funding Round
  • Norway, United Kingdom
Portfolio highlights
  • APIM Therapeutics — APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellularresponses to DNA damage and stress.
  • Zelluna Immunotherapy — Zelluna Immunotherapy AS is a privately owned biopharmaceutical company focused on the development of TCR based immunotherapies.
  • Accession Therapeutics — Accession Therapeutics’ elegant Trocept platform has potential to treat some of the most intractable and widespread forms of cancer. Based in Oxford, UK, it is developing a pipeline of products to the early clinical trial stage. Led by Bent Jakobsen, PhD FMedSci, a pioneer of T cell receptor therapy for cancer, the team is highly experienced intaking immuno-oncology products to the clinic. Accession Therapeutics’ Trocept technology is based on over a decade’s work and has generated exceptional preclinical data.Accession Therapeutics’ proprietary technology incorporates cancer-tropic viruses, the first time that viruses have been genetically modified to exclusively target cancer cells. As non-cancerous cells are not targeted by Trocept, systemic toxicity is eliminated meaning the drugs can be delivered intravenously and traffic to the tumour. Trocept’s highly potent and local activity gives it potential in some of the hardest to treat and most widespread forms of cancer. This includes breast, cervical, colorectal, gastric, head and neck, lung, oral, ovarian and pancreatic cancer.
The Index Project VC Fund · Copenhagen, Hovedstaden, Denmark
Design to improve life is about solving real problems, small and large, simple and complex, systemic and emerging and is a life-long pursuit. The Index Project is a call to action. Are you in?
Show more
Investment focus
  • Artificial Intelligence, Chemical, SaaS
  • Seed, Series A, Series B
  • United States, Denmark, Chile
Portfolio highlights
  • Agribuddy — Management of agricultural support application "AGRIBUDDY".
  • CanopyLAB — The Future of Learning. Delivered Today.
  • Destácame — Destacame is the first behavior-based credit score in Latin America.
Canica VC Fund · Oslo, Oslo, Norway
Canica is one of the largest privately owned investment companies in Norway. Our operations are focused on active, long-term ownership, primarily within sectors covering retail, fast moving consumer goods and real estate. Canica can offer core expertise within the fields of business development and finance, as well as capital and network in orderto create value and employment in a long-term perspective.
Show more
Investment focus
  • Beauty, Medical, Biotechnology
  • Private Equity, Series A, Series D
  • Norway, Denmark, Switzerland
Portfolio highlights
  • Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
  • Porterbuddy — They are the gang that delivers to your door the same day you order in the online store.Porterbuddy'​ is a logistics platform that provides efficient and customer-centric, last-mile delivery of products.
  • Galecto — Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The company lead product candidate, GB0139, is an inhaled inhibitor of galectin-3. GB0139 is being developed for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, in which there is high unmet medicalneed. Galecto was founded in 2011, builds on more than 10 years of research centering on the role of galectin-3 and LOXL-2, and the use of modulators of these proteins to treat fibrosis-related diseases and cancer. Combined with a strong patent estate, these assets give Galecto a unique therapeutic platform.
Project Sandwater VC Fund · Oslo, Oslo, Norway
Project Sandwater is a fresh take on venture investments within the Nordics and beyond.
Show more
Investment focus
  • Medical, Consulting, Life Science
  • Series A
  • Norway, The Netherlands
Portfolio highlights
  • Delft IMP — Delft IMP (Intensified Materials Production) commercializes nanostructuring of particles using atomic and molecular layer deposition (ALD and MLD), based on the patented and publicized IP and know-how developed within the Product & Process Engineering (PPE) group at Delft University of Technology. Following various feasibility projects betweenindustry and university, Delft IMP was initiated end 2014 to truly commercialize the technology.
  • Cytovation — Cytovation AS is a privately-held biotech company, specialising in dermatological diseases, based in Bergen, Norway.
Nordic Impact VC Fund · Oslo, Oslo, Norway
Nordic Impact invests in, supports, and builds businesses and funds based around technology. The company's goal is to make impact investing mainstream and mobilize all business and capital towards solving the big problems in the world while making great financial returns.
Show more
Investment focus
  • Chemical, Life Science, Visual Search
  • Seed
  • Norway
Portfolio highlights
  • Iris.ai — Powerful Tools for Your Research. We have built a world-leading AI engine for scientific text understanding. Applied to literature reviews, data extraction, post-market surveillance or any other task involving thousands of documents like papers or patents, this engine will make your life a whole lot easier.
Bakken & Baeck VC Fund · Oslo, Oslo, Norway
A technology-driven design studio. Building digital products, brands and businesses, we help ambitious companies identify, explore and respond to new opportunities.
Show more
Investment focus
  • Chemical, Software, Life Science
  • Seed, Angel
  • Norway
Portfolio highlights
  • Versor — Versor develops software necessary for true autonomous drone flight both indoors and outdoors, enabling complete automation of industrial drone operations. They believe this level of automation requires superior localization, which is particularly difficult to achieve indoors and in GPS-denied areas. By removing the need for pilots, entire fleetsof drones may be supervised remotely, enabling true scalability of drone operations across various applications.
  • Iris.ai — Powerful Tools for Your Research. We have built a world-leading AI engine for scientific text understanding. Applied to literature reviews, data extraction, post-market surveillance or any other task involving thousands of documents like papers or patents, this engine will make your life a whole lot easier.
Investors by industry
Investors by country
VC Funds in Norway by industry